David Goel - Director, Adaptive Biotechnologies Corp

As of March 10, 2021


David Goel Net Worth

  • Net worth is estimated to be at least $472.87M
  • Owns at least 12,310,594 units of Adaptive Biotechnologies Corp stock
  • Sold an estimated value of $170.98M in the last 2 years at Adaptive Biotechnologies Corp

David Goel Trading

  • Largest sale of shares was 2,000,000 units , worth over $80M on July 22, 2020
  • In total has made about 4 transactions over 2 years
  • Usually trades in July, with the busiest year in 2020

DAVID GOEL, Matrix Capital Management Company LP

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Goel Mailing Address

  • Mailing address is C/o Matrix Capital Management Co., Lp 1000 Winter Street, Suite 4500 Waltham MA 02451 MA

Adaptive Biotechnologies Corp Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Chad Robins 2020 $597,400 - $500,000 $500,000 $20,098 $7,131,118
Chad Robins 2019 $492,555 - $385,950 $385,950 - $2,856,181
Chad Robins 2018 $422,815 - $266,500 $266,500 - $3,194,658
Chad Cohen 2020 $411,950 - $210,000 $210,000 $3,943 $2,329,752
Chad Cohen 2019 $381,413 - $193,900 $193,900 - $1,130,027
Chad Cohen 2018 $359,188 - $158,500 $158,500 - $1,144,024
Harlan Robins, PhD 2020 $493,750 - $250,000 $250,000 $3,900 $6,761,270
Harlan Robins, PhD 2019 $431,846 - $237,500 $237,500 - $2,647,022
Harlan Robins, PhD 2018 $348,938 - $158,500 $158,500 - $2,177,666
Harlan Robins, PhD 2020 $481,100 - $250,000 $250,000 $3,675 $4,743,855
Harlan Robins, PhD 2019 $412,050 - $212,200 $212,200 - $1,709,560
Harlan Robins, PhD 2018 $368,753 - $187,500 $187,500 - $2,226,481
Harlan Robins, PhD 2020 $280,859 $1,405,000 $112,022 $112,022 $10,523 $2,699,999
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1478320/000156459021020371/adpt-def14a_20210611.htm

Adaptive Biotechnologies Corp Insider Trading

  • The most recent transaction was 831 units sold on April 8, 2022 by R. Mark Adams worth over $10.94K
  • In the last 13 years, insiders at Adaptive Biotechnologies Corp sold an estimated value of $1.27B and bought an estimated value of $142.7M
  • The most active traders are Steel Partners Holdings Lp,  Steel Partners Llc,  and Warren Lichtenstein, President Subsidiary
  • Insider trading is most common in February, with the busiest year in 2020

Adeptus Health Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1